Establishment of assay system for beta-site APP cleaving enzyme activity and evaluation of inhibitors
碩士 === 國立臺灣大學 === 藥學研究所 === 92 === Alzheimer’s disease (AD) is a progressive neurodegenerative disorder often associated with elderliness and adult Down’s syndrome individuals. It is characterized pathologically of the intraneuronal neurofibrillary tangles (NFT) and the extracellular senile plaques...
Main Authors: | Chiung-Yi Huang, 黃瓊誼 |
---|---|
Other Authors: | 孔繁璐 |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/15405481940629533517 |
Similar Items
-
Biological evaluation and interaction mechanism of beta-site APP cleaving enzyme 1 inhibitory pentapeptide from egg albumin
by: Zhipeng Yu, et al.
Published: (2020-06-01) -
Cloning and characterization of b-site APP cleaving enzyme (BACE)-type I.
Published: (2002) -
The Identification of Biochanin A as a Potent and Selective β-Site App-Cleaving Enzyme 1 (Bace1) Inhibitor
by: Kumju Youn, et al.
Published: (2016-10-01) -
Icaritin, an inhibitor of beta-site amyloid cleaving enzyme-1, inhibits secretion of amyloid precursor protein in APP-PS1-HEK293 cells by impeding the amyloidogenic pathway
by: Fei Feng, et al.
Published: (2019-12-01) -
HUBUNGAN KADAR BETA.SITE APP.CLEAVING ENZYME 1, BETA-AMYLOID DAN 4 HYDROXINONENAL PLASMA DENGAN GANGGUAN FUNGSI KOGNITIF PADA PENDERITA PASCASTROKE ISKEMIK
by: Yuliarni Syafrita, et al.
Published: (2014-12-01)